CNS Pharmaceuticals (CNSP) Live Share Price, Invest From India

CNS Pharmaceuticals Stock Performance

as on October 17, 2026 at 2:15 pm IST

Day's Low
Day's High
$4.65
Day's Price Range
$5.00
$4.85
4.12%
Downside
3.09%
Upside
52 Week's Low
52 Week's High
$1.90
52-Week Price Range
$10.54
$4.85
60.82%
Downside
117.32%
Upside

CNS Pharmaceuticals share price movements today

Previous Close: $5.18
Open: $5.00
Volume: 825.6K
Market Cap: $7.6M
Day's Low - High: $4.65 - $5.00
52 Week Low - High: $1.90 - $10.54

CNS Pharmaceuticals Historical Returns

1 Month Return: -5.25 %
3 Month Return: -3.75 %
1 Year Return: -47.27 %
3 Year Return: -99.99 %
5 Year Return: -100 %

CNS Pharmaceuticals Stock Fundamentals & Key Indicators

Check CNS Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.6M

EPS (TTM)

-23.59

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.22

Industry PE ratio

-2.36

PEG Ratio

-0.00

EBITDA

-16.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-204.25%

CNS Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CNS Pharmaceuticals with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
CNS Pharmaceuticals	Hold	$7.6M	-100.00%	-0.22	0.00%	0.00%
Moderna	Neutral	$94.4B	-32.76%	-29.64	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$128.9B	174.93%	29.37	86.04%	0.00%
Regeneron	Buy	$80.1B	42.93%	19.01	84.86%	0.46%

Stock Returns calculator for CNS Pharmaceuticals Stock including INR - Dollar returns

The CNS Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

CNS Pharmaceuticals investment value today

Current value as on today

₹56,885

Returns

-₹43,115

(-43.11%)

Returns from CNS Pharmaceuticals Stock

-₹47,283 (-47.28%)

Dollar Impact

₹4,168 (+4.17%)

Analyst Recommendation on CNS Pharmaceuticals Stock

Based on 6 analysts

HOLD

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for CNS Pharmaceuticals. Average target price of $10

CNS Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on CNS Pharmaceuticals.

What analysts predicted

51.5%UPSIDE

Target Price

$10

Current Price

$4.85

Analyzed by

6 Analysts

Target

$10.00

CNS Pharmaceuticals target price $10, a slight upside of 51.5% compared to current price of $4.85. According to 6 analysts rating.

Indian Investors' Interest in CNS Pharmaceuticals Stock

Search interest for CNS Pharmaceuticals Stock has decreased by -16% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 18, 2026 to October 18, 2026

Change:-16% versus previous 30 day period

CNS Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	-
Operating Income	-4	-3	-2	-5	-4	-2	-3	-5	-4	-2
EBITDA	-4	-3	-2	-5	-4	-2	-3	-5	-4	-2
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-3	-2	-5	-4	-2	-3	-5	-4	-2
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-4	-3	-2	-5	-4	-2	-3	-5	-4	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

CNS Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Mar 2024	Mar 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	0	0	0	0	0	-
Operating Income	0	0	-3	-9	-14	-14	-18	-14	-15
EBITDA	0	-6	-3	-9	-14	-15	-18	-14	-15
Interest Expense	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	0	-7	-3	-9	-14	-15	-18	-14	-15
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	0	-7	-3	-9	-14	-15	-18	-14	-15
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

CNS Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-4	-3	-2	-5	-4	-2	-3	-5	-4	-2
Operating Cash Flow	-3	-3	-1	-6	-3	-5	-2	-3	-4	-3
Investing Cash Flow	0	-	-	-	-	-	-	0	0	0
Financing Cash Flow	0	3	2	12	9	4	0	0	0	20
Change in Cash	-3	0	0	5	6	0	-2	-2	-4	17

CNS Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Mar 2024	Mar 2025	Dec 2025
Net Income	0	-7	-3	-9	-14	-15	-18	-14	-15
Operating Cash Flow	0	0	-3	-7	-13	-10	-14	-17	-13
Investing Cash Flow	-	-	0	0	0	0	0	0	0
Financing Cash Flow	0	1	10	14	4	15	4	23	14
Change in Cash	0	0	6	6	-9	5	-9	5	0

Global Institutional Holdings in CNS Pharmaceuticals

Check out the Institutions with significant holdings in CNS Pharmaceuticals.

Funds	Holdings
Vanguard	0.48%
Fidelity Concord Street Trust	0.47%

Insights on CNS Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, CNSP stock has moved up by 91.0%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 785.5%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 152.5% return, outperforming this stock by 252.5%

About CNS Pharmaceuticals

CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.

Organisation	CNS Pharmaceuticals
Headquarters	2100 West Loop South, Houston, TX, 77027, US
Industry	Biotechnology
CEO	Rami Levin

Key Management of CNS Pharmaceuticals

Name	Title
Mr. Rami Levin M.B.A.	President, CEO & Director
Mr. Steve O'Loughlin M.B.A.	Chief Financial Officer
Mr. Eric Faulkner M.B.A., M.Sc.	Chief Technology Officer
Mr. Dylan Wenke M.B.A.	Chief Business Officer
Dr. E. Lynne Kelley F.A.C.S., M.D.	Chief Medical Officer

FAQs

What is CNS Pharmaceuticals share price today?

CNS Pharmaceuticals share price today is $4.85 as on October 17, 2026 at 8:45 am IST at the close of the market. CNS Pharmaceuticals share today touched a day high of $5.00 and a low of $4.65.

What is the 52 week high and 52 week low for CNS Pharmaceuticals share?

CNS Pharmaceuticals share touched a 52 week high of $10.54 on May 4, 2026 and a 52 week low of $1.90 on April 22, 2026. CNS Pharmaceuticals stock price today i.e. October 17, 2026 at 8:45 am IST is closed at $4.85,which is 53.98% down from its 52 week high and 155.26% up from its 52 week low.

What is CNS Pharmaceuticals's market capitalisation today?

CNS Pharmaceuticals market capitalisation is $0.00T as on October 17, 2026 at 8:45 am IST.

How to invest in CNS Pharmaceuticals Stock (CNSP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for CNS Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy CNS Pharmaceuticals Stock (CNSP) from India?

Indian investors can start investing in CNS Pharmaceuticals (CNSP) shares with as little as ₹94.95999908447266 or $1 (as of October 18, 2026 at 4:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in CNS Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on October 18, 2026 at 4:38 am IST). Based on CNS Pharmaceuticals share’s latest price of $4.85 as on October 17, 2026 at 8:45 am IST, you will get 2.0619 shares of CNS Pharmaceuticals. Learn more about fractional shares .

What are the returns that CNS Pharmaceuticals has given to Indian investors in the last 5 years?

CNS Pharmaceuticals stock has given -100% share price returns and 26.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?